Pharmacokinetics and systemic effect on calcium homeostasis of 1α-24-dihydroxyvitamin D2 in rats. Comparison with 1α,25-dihydroxyvitamin D2, calcitriol, and calcipotriol

Biochemical Pharmacology

Volumn 53, Issue 6, 1997, Pages 829-837

  Knutson, Joyce C ^a   LeVan, Leon W ^a   Valliere, Charles R ^a   Bishop, Charles W ^a  

^a Bone Care International   (United States)

Author keywords

1 ,25 dihydroxyvitamin D2; 1 ,25 dihydroxyvitamin D3; 1 24 dihydroxyvitamin D2; calcipotriol; calcium; pharmacokinetics; vitamin D analogs

Indexed keywords

1ALPHA,24 DIHYDROXYVITAMIN D2; CALCIPOTRIOL; CALCITRIOL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOAVAILABILITY; CALCIUM HOMEOSTASIS; CONTROLLED STUDY; DRUG BLOOD LEVEL; FEMALE; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; VITAMIN D DEFICIENCY;

ANIMALS; BIOLOGICAL AVAILABILITY; CALCITRIOL; CALCIUM; DOSE-RESPONSE RELATIONSHIP, DRUG; ERGOCALCIFEROLS; HOMEOSTASIS; MALE; RATS; VITAMIN D DEFICIENCY;

EID: 0030964795     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(97)00004-X     Document Type: Article

References (20)

1. DeLuca HF, Krisinger J, Darwish H, The vitamin D system: 1990. Kidney Int 38 (Suppl 29): S2-S8, 1990.
2. Suda T, Shinki T and Takahashi N, The role of vitamin D in bone and intestinal cell differentiation. Annu Rev Nutr 10: 195-211, 1990.
3. Jones G and Calverley MJ, A dialogue on analogues: Newer vitamin-D drugs for use in bone disease, psoriasis, and cancer. Trends Endocrinol Metab 4: 297-303, 1993.
4. 2. Arch Biochem Biophys 202: 450-457, 1980.
5. 2 in mammals. Biochemistry 29: 578-582, 1990.
6. 2 in disorders of mineral metabolism in humans. J Bone Miner Res 10 (Suppl 1):S289, 1995.
7. 2 made in the human hepatoma, Hep3B. Biochem J 310: 233-241, 1995.
8. 3 in rats and monkeys. Endocrinology 136: 4749-4753, 1995.
9. 2 in normal and immortalized human epidermal cells. Biochem Pharmacol 52: 133-140, 1996.
10. 3 in the rat. Proc Soc Exp Biol Med 178: 432-436, 1985.
11. 2 partially dissociates between preservation of cancellous bone mass and effects on calcium homeostasis in ovariectomized rats. Calcif Tissue Int, in press.
12. 2 analogs on calcium metabolism in vitamin D-deficient rats and in MC3T3-E1 osteoblastic cells. Res Exp Med (Berl) 191: 235-242, 1991.
13. Sjöden G, Lindgren JU and DeLuca HF, Antirachitic activity of 1α-hydroxyergocalciferol and 1α-hydroxycholecalciferol in rats. J Nutr 114: 2043-2046, 1984.
14. 2: A new look at an "old" compound. Nephrol Dial Transplant 11 (Suppl 3): 153-157, 1996.
15. 3. Biochem Pharmacol 41: 1601-1606, 1991.
16. Kissmeyer A-M, Mathiasen IS, Latini S and Binderup L, Pharmacokinetic studies of vitamin D analogues: Relationship to vitamin D binding protein (DBP). Endocrine 3: 263-266, 1995.
17. 3: Effects on cell growth regulation in vitro and calcium metabolism in vivo. Pharmacol Toxicol 72: 240-244, 1993.
18. 2 in rats following oral administration. J Bone Miner Res 8: S224, 1993.
19. Hollis BW, Assay of circulating 1,25-dihydroxyvitamin D involving a novel single-cartridge extraction and purification procedure. Clin Chem 32: 2060-2063, 1986.
20. Dusso AS, Negrea L, Finch J, Kamimura S, Lopez-Hilker S, Mori T, Nishi Y, Brown A and Slatopolsky E, The effect of 22-oxacalcitriol on serum calcitriol. Endocrinology 130: 3129-3134, 1992.